Introduction: Unexplained Recurrent Spontaneous Abortion (URSA) is the most common immunological complication during pregnancy. It has been found that the cells such as human amnion epithelial cells (hAECs) have the potency to modulate immune responses in vitro and in vivo. In the present study, we assessed the immunomodulatory effect of hAECs on NK cells and T cells in women with URSA.
Introduction
Recurrent Spontaneous Abortion (RSA) is the most common immunological complication during pregnancy and defined as two or more sequential miscarrages before the 20 th week of gestation, which affects approximately 1% to 5% of couples. [1] [2] [3] Many causes have been postulated to play a role in the etiology of RSA, however in more than half of RSA cases, the etiology is unknown which, this condition is defined as Unexplained Recurrent Spontaneous Abortion (URSA). [4] [5] [6] [7] Immunological factors in both innate and adaptive immunity may be involved in RSA pathogenesis. [8] [9] [10] [11] It has recently been shown that URSA is similar to an alloimmune condition [9] and evidence of in vitro assays has shown that immune cells such as T (CD3 + ) and NK (CD56 + ) cells are responsible for embryotoxicity. Also, the numbers and activities of these cells are suppressed in normal pregnancies. [12] [13] [14] [15] NK cells are effector lymphocytes of the innate immune system which are present in peripheral blood and in the uterine and play an important role in maintaining pregnancy. [16, 17] These cells are the most abundant population of lymphocytes (about 70-90%) in the uterine implantation site.
According to the cell surface markers, NK cells are generally divided into CD56 dim /CD16 + and CD56 bright /CD16 − NK cells groups. CD56 bright /CD16 − NK cells are mainly found in the uterine (UNK) whereas NK population in peripheral blood (PNK) are principal of the CD56 dim /CD16 + NK cells which unusual changes of them may affect uterine NK cells. [18] The systemic regulation of NK cells (UNK/ PNK) contributes to reproductive success. [16] Several studies have reported increased levels and cytotoxicity of peripheral blood NK cells in RSA compared to pregnant or non-pregnant women. [19] [20] [21] [22] Furthermore, several studies have also reported that PBMCs from women with RSA have increased activated CD3 + T cells as compared with normal fertile women. [23, 24] Human Amniotic Epithelial Cells (hAECs) with immunomodulatory effects are the candidate as a novel stem cell therapy. [25, 26] These cells release some factors with anti-inflammatory properties which can inhibit immune cells in both the innate and adaptive immune systems. [27] Numerous recent investigations have demonstrated that hAECs are able to produce soluble factors such as MIF (migration inhibitory factor), TRAIL, TNF-a, FasL, TGF-b (Transforming Growth Factor-b) and PGE2 (prostaglandin E2). It has also been shown, that freshly isolated hAECs have low immunogenicity because they express low levels of HLA-class I and lack HLA-class II expression. These cells have stem cell-like properties and are not tomorgenic. [25, 26, [28] [29] [30] [31] [32] [33] [34] According to the abovementioned descriptions, hAECs have features that may act as an immunomodulatory agent for different diseases. So this has motivated us to investigate the effect of hAECs on activation and cytotoxic activity of NK and T cells by in-vitro co-culture of these cells with peripheral blood NK cells and T cells from women with (RSA).
Materials and Methods

Isolation of hAEC
Fourteen human placentas were collected from women with elective normal cesarean deliveries (37-40 weeks). After explaining the purposes of the research, oral and written informed consent was obtained. Amniotic membrane was mechanically stripped from corion and placed in RPMI 1640 (Gibco) medium culture containing penicillin/streptomycin (Gibco), then was transferred to the laboratory. Human Amniotic Epithelial Cells (hAECs) were isolated using the procedure as previously defined [35] [36] [37] , with minor modifications. Briefly, an amniotic membrane was rinsed 2 or 3 times with phosphate-buffered saline (PBS) and washed amnion was cut into small pieces and was digested thrice in 0.05% trypsin (Gibco): EDTA at 37°C in a shaking water bath for 20 min. Following digestion, trypsin was inactivated with fetal bovine serum (FBS) (Gibco) and the hAECs were collected by centrifugation (1800 RPM, 5 min) and suspended in DMEM/F12 culture medium (Gibco). Isolated hAECs were typically ≥95% pure witch calculated for cytokeratins 7, 8/18 by flow cytometry. The cells were counted and their viability was determined using trypan blue and finally plated in flat-bottomed tissue culture plates to perform co-culture experiments.
Patients and Samples
Human peripheral blood samples were collected from 14 women with unexplained RSA who had two or more consecutive RSA. The average age of patients was between 21-41 years. After explaining the purposes of the study, oral and written informed consent was taken and the study was approved by the ethics committee from the Isfahan University of Medical Sciences. URSA patients with immune diseases, infectious diseases, metabolic diseases, congenital thrombophilia, autoimmune diseases and patients under immunotherapy were excluded from this study.
PBMC isolation, activation and co-culture with hAEC
Peripheral blood mononuclear cells (PBMC) were isolated by the Ficoll-Hypaque (Biosera, France) density gradient centrifugation, washed three times and then resuspended in RPMI 1640 medium culture. 1 × 10 6 PBMCs/well were cultured alone or co-cultured with isolated hAECs in RPMI1640 (Gibco) supplemented with 10% FBS (Gibco), 2 mM glutamine, Penicillin (100 U/mL) and Streptomycin (100 μg/mL) (Gibco) and IL-2 (100unit/ mL) (eBiosciences, USA) at ratios of 1:5, 1:1, 5:1 hAECs/ PBMCs for 3 days. The cultures were incubated at 37°C in a fully humidified atmosphere of 5% CO 2 . All co-cultured were compared to PBMCs culture in complete medium plus IL-2 cytokine alone without hAECs.
Mixed lymphocyte reactions (MLR)
Human Amniotic Epithelial Cells (hAECs) alloreactivity was assessed by mixed lymphocyte reaction (MLR). In brief, responder PBMCs were cultured in a 96-well flatbottom tissue culture plate along with hAECs as stimulator at 1:1, 1:2, 1:3 ratios for 3.5 and 8 days in duplicate. The proliferative allogeneic reaction was determined using a proliferation BrdU cellular ELISA Kit (Abnova. Taiwan). Positive control consisted of PBMCs plus anti-CD3 and anti-CD28 (all ebiosciences, USA) alone. Negative controls consisted of PBMC alone and hAE cells alone in culture media.
Flow cytometry
After incubation for 3 days, the cells were washed three times with PBS and blocked by a human FC blocker solution (Miltenyi, Biotec, USA). Cells (2-3×10 5 ) were resuspended in 1 ml PBS with 1% FBS, and were stained by use of the following conjugated mAbs for 45 min at 4 °C in the dark: mouse anti-human CD3-FITC, mouse antihuman CD56, mouse anti-human CD69 and CD107a (all eBiosciences San Diego, CA, USA). The following isotype controls were used: Mouse IgG1 K-FITC, Mouse IgG1 K-PE, Mouse IgG1 K PE-Cy5 (all eBiosciences San Diego, CA, USA). Flow cytometry was carried out on a BD FACSCalibur cytometer (Becton Dickinson, San Jose, CA) and 20.000 cells were counted in each experiment. Data analysis was performed with the CellQuest software (Becton Dickinson). In order to identify lymphocyte populations, we first gated on cells based on forward (FSC) and side scatter (SSC) properties. This population was gated further as NK cells and T cells, on viability as assessed by CD56 positivity, CD3 negativity, and CD56 negativity, CD3 positivity respectively.
Assay of CD107a degranulation
Cytotoxic granules in NK cells contain different lytic enzymes such as perforin, granzyme and the lysosome-associated membrane proteins CD107a/LAMP-1. [38] CD107a is a marker of NK cells cytotoxic activity which its surface expression has been frequently used as a marker for degranulation. [39] Cytokine-stimulated (IL-2, 150 U/mL) PBMCs were cocultured with human amniotic epithelial cells at ratios of 1:5, 1:1, 5:1 hAECs/PBMCs for 3 days. The cells were then stained with PE-conjugated anti-human CD107a mAb and incubated for 5 h in a humidified incubator with 5% CO 2 at 37°C. Monensin (Biolegend) was added to each well at a final concentration of 6 μg/mL during the last 4 h of the culture to inhibit the degradation of CD107a from the cell surface and ensure the detectability of this marker after stimulation. To determination of the background level of degranulation unstimulated PBMCs were similarly treated in parallel and IL-2 (100 U/mL) stimulated PBMCs served as the positive control. Following 5 h incubation, cells were harvested and stained with FITC-conjugated anti-human CD3, PE-Cy5conjugated anti-human CD56 (eBiosciences San Diego, CA, USA) for NK and T cell detection. Populations of NK cells were defined as lymphocytes that were CD3negative and were further defined by their expression of CD56. Cd107a expression on CD3 − CD56 + NK cells and CD3 + CD56 − T cells was examined on a FACS Calibur flow cytometer (BD Bioscience, San Jose, CA, USA).
Flow cytometric analysis of CD69 expression
CD69 expression was assessed on NK and T cells by means of flow cytometry in order to identify NK and T cells activation. The detection of activated cells was assayed by using FITC-anti-CD3, PE-Cy5-anti-CD56 and PE-anti-CD69 (all eBiosciences San Diego, CA, USA) in cold PBS plus 1% BSA. A cell gate region was drawn around lymphocytes in order to exclude debris. The NK cells were defined as lymphocytes that were CD3-negative and were further defined by their expression of CD56. The expression of surface CD69 was assessed in the CD3 − CD56 + NK cells and CD3 + CD56 − T cells gated population by FACS Calibur flow cytometer (BD Bioscience, San Jose, CA, USA).
Statistical analysis
All statistical analyses were performed using SPSS Statistics version 20.0 (2011, SPSS Inc., Chicago, IL, USA). A twotailed t-test was used to analyze the results between study subjects and controls. The statistical comparisons among groups (doses) were performed using univariate analysis of variance. The results were reported to be statistically significant if the P value was <0.05.
Results
Purity of hAECs and their Effects on proliferative allogenic response in PBMCs
Isolated hAECs were typically ≥95% pure witch calculated for cytokeratins 7, 8/18 by flow cytometry (Fig. 1a) . We analyzed the in vitro allogenic effect of hAECs in cocultured assay that incorporated hAECs together PBMCs. In contrast to the highly proliferative reaction induced by PMA/I and anti-CD3/anti-CD28 stimulation in positive control (p=0.0001), hAECs did not stimulate a proliferative allogenic response when cultured with PBMCs in different doses and days (Fig. 1b ).
Downregulation of CD107a expression in NK cells by Human amnion epithelial cells (hAECs)
The cell surface expression of CD107a on NK cells (CD3 − CD56 + ) incubated with hAECs was significantly decreased at a ratio of 5:1 (22.5±14.2) for 3 days compared with control (32±17.5). Moreover, the comparison between 3 different ratios was shown that the expression of CD107a on CD3 − CD56 + NK cells was significantly lower in cocultured hAECs and PBMCs at the ratio of 5:1 (p=0.007) as compared with two other ratios (1:1 and 1:5) ( Fig. 2) . Also, we did not find a significant difference between CD56 dim and CD56 bright NK cells in CD107a expression. The range of values is shown in Table 1 .
Suppression of CD69 expression in NK cells by Human amnion epithelial cells (hAECs)
To evaluate the effect of hAECs on NK-cell activation potential, PBMCs were co-cultured with hAECs cells for 3 days. Flow cytometric analysis revealed a significant decrease in CD69 expression on NK cells at high concentration of hAECs in co-cultured group (5:1) (35.2±18.5) compared to control (45.9± 22.5) (p=0.049). However, no significant differences were observed in CD69 expression between 3 co-cultured ratios (Fig. 3 ).
Downregulation of CD107a expression in T cells by Human amnion epithelial cells (hAECs)
We also assessed the impact of the hAECs on the T cell surface expression of CD107a. Flow cytomery analysis shown a significant decrease in CD107a expression on T cells at 1:1 (10.8±4.1) (p=0.003) and 5:1 (9.7±3.1) (p=0.003) ratios as compared with control (13.73±3.3) ( Fig. 4) . No significant changes in CD107a expression were observed between 3 different co-cultured groups. Figure 1. A, B. Purity of hAECs and their allogeneic effects on PBMCs. A: Isolated hAECs were analyzed with pan-cytokeratin markers (7, 8/18) labeled with FITC and the purity of cells was typically ≥95%. B: PBMCs were co-cultured with different numbers of hAECs for 3 days. A BrdU cellular ELISA kit was used to measure alloreactive response of PBMCs. Stimulated PBMCs with anti-CD3/CD28 antibodies were used as positive control. The depicted results are representative of 4 independent experiments. All data show mean ± SEM.
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Suppression of CD69 expression in T cells by Human amnion epithelial cells (hAECs)
To confirm whether hAECs suppresses T cell activation, we explored the expression level of CD69 in T cells after IL-2 stimulation followed by the treatment with or without hAECs ( Fig. 5 ). As shown in Figure 5 , the expression of CD69 on CD3 + CD56 − T cells was significantly decreased in all co-cultured groups (1:5, 1:1, 5:1) (8±3.2, 6.9±2.9, Intra-group significant difference (p≤0.05) between control and co-cultured hAECs/ PBMCs at ratio of 5:1 b Intra-group significant difference (p≤0.05) between control and co-cultured hAECs/ PBMCs at ratio of 1:1 Figure 2. A, B . Effect of hAECs on NK-cells CD107a expression (A and B) . Also, no significant difference between the three hAECs ratios in co-cultured groups was observed.
Discussion
Several studies have recently shown that hAECs possess potent immunosuppressive and immunomodulatory
properties. [31] These cells like other fetal-derived placental cells evade maternal immune detection and secrete factors known to suppress maternal immune reactions against the fetal semi-allograft. [40] Additionally, the presence of pathogenic autoantibodies such as anti-phospholipid antibodies (APAs), anti-thyroid antibodies (ATAs), and the pathologic role of cellular immunity, NK cells and, NKT cells have been reported in women with RSA. [41] [42] [43] [44] According to immunomodulatory properties of hAECs, Figure 5. A, B . T-cell activation is affected by hAECs. (A and B) . Freshly isolated PBMCs from women with RSA (n=14) were treated with indicated ratios of hAECs and without hAECs as control. A: CD69 expression on CD56 − /CD3 + T cells was analyzed by flow cytometry with gating strategy. Representative FACS dot plots of CD69 + T cells analysis are presented. In order to identify lymphocyte populations, we first gated on cells based on forward (FSC) and side scatter (SSC) properties. This population was gated further as T cells on viability as assessed by CD56 negativity and CD3 positivity. we examined whether co-culture of hAECs with PBMCs of URSA patients could modulate expression of early activation marker CD69 and a cytotoxic activity marker CD107a, on NK cells and T cells.
To our best of knowledge, for the first time, we found that CD107a and CD69 expression was significantly decreased on CD3 − CD56 + NK cells and CD3 + CD56 − T cells after treatment with hAECs dose dependently. CD107a is a marker of degranulation on lymphocytes such as CD8+ T cells, NK cells. [45] This marker is upregulated on these cells following stimulation and its induction is accompanied by cytokine secretion and target cell lysis. In addition, CD107a may express on the large piece of activated NK cells that may degranulate in the absence of cytokine secretion. There is a bidirectional regulation between NK cells and other immune cells especially CD4 + T cells in autoimmune disorders [55] and dysregulation between these cells is possibly happened in RSA to change the immunosuppressive environment required for fetal tolerance. Some immunomodulatory characteristic of hAECs such as low levels of HLA Class IA, lack of costimulatory molecules CD80/86 and secretion of TGF-b and IL-6 have indicated in different studies. [40, 56, 57] The in vitro assessment of hAECs allogenic effects in our study indicated that hAECs did not stimulate a proliferative allogenic response when cultured with PBMCs. According to previous studies, since hAECs cells do not express HLA class IA and HLA-DR molecules, our consequence is expected. [58, 59] Human AECs express HLA-G on their surface or in soluble form and Lim et al. have indicated term hAECs express higher levels of HLA-G compared to preterm hAECs. [60] The highest expression of HLA-G is in the placenta, where its main role involves protection of the semi-allogenic fetus from allo-reactive immune responses. However, yet there is still very limited data on the cytotoxicity role of NK cells and T cells and immune regulatory effects of hAECs in RSA. Further study is needed to investigate hAECs effect on cytotoxic activity of NK cells and T cells in women with URSA.
Different studies have demonstrated hAECs that hAECs due to their anti-inflammatory properties could be used to alleviate the burden of some diseases such as MS, inflammation-induced fetal lung injury and liver disease.
[30, 66, 67] So, it seems that hAECs may interfere with the early phase of T and NK cells activation and could be used for attenuate immunologic responses in RSA however more detailed studies are needed to link the observed phenotypic changes with a biological implication of CD69 and CD107a downregulation in the control of RSA. However, our study was limited by a small study population, the absence of a pathophysiologic investigation of T cells, NK cells and NKT cells, and no data regarding cytokines, activatory and inhibitory receptors. Also, due to limitation in flow cytometry staining (we had 3 colors flow cytometry) we could not assess CD107a expression on CD3-CD16 bright NK cells and CD3 + CD8 + T cells.
Conclusion
According to this study hAECs are capable of decreasing the activation and cytotoxic activity of CD56 − CD3 + T cells and CD56 + CD3 − NK cells and this could make hAECs an attractive candidate of cellular therapy for women with URSA.
